-
Mashup Score: 4The Advances in Cancer Immunotherapy - SITC - OncoDaily - 2 month(s) ago
The Advances in Cancer Immunotherapy – SITC / Advances in Cancer Immunotherapy, bladder cancer, cancer, Genitourinary Cancers, OncoDaily, Oncology, SITC,
Source: oncodaily.comCategories: General Medicine NewsTweet
-
Mashup Score: 2A T cell receptor β chain-directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity - PubMed - 7 month(s) ago
Despite the success of programmed cell death-1 (PD-1) and PD-1 ligand (PD-L1) inhibitors in treating solid tumors, only a proportion of patients respond. Here, we describe a first-in-class bifunctional therapeutic molecule, STAR0602, that comprises an antibody targeting germline Vβ6 and Vβ10 T cell …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
For more reading... 👉https://t.co/l2esNkEi37
-
-
Mashup Score: 3Marengo Therapeutics - 7 month(s) ago
Pioneering a brand-new way to activate the body’s own immune system to mount a rapid, effective, and durable response against cancer.
Source: marengotx.comCategories: General Medicine News, Hem/OncsTweet-
And I have so many people to thank for helping on this study. Certainly I thank my wonderful co-investigators, the patients and their families and the incredible people at Marengo Therapeutics (https://t.co/XikLZ5V9zj). https://t.co/7b9OGS0DfL
-
-
Mashup Score: 9Sweep the Creek Video Clip - 9 month(s) ago
Before & After at Long Branch Park during the 2024 Sweep the Creek.#friendsofsligocreek #cleanup #protectingtheenvironment #sligocreek #longbranch
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
My fun last Sunday! https://t.co/XCioevNDCI
-
-
Mashup Score: 18Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020 - 10 month(s) ago
AbstractBackground. We described participant demographics for National Cancer Institute (NCI) clinical trials at the clinical center (NCI-CC participants)
Source: academic.oup.comCategories: General Medicine News, Hem/OncsTweet-
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020 https://t.co/gIpGIZkT1h
-
-
Mashup Score: 1
The EDEN Study is a clinical trial conducted by the National Cancer Institute (NCI) investigating the link between diet, exercise, and changes in your gut mi…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
We have a study looking at the diversity of the gut microbiome in patients with melanoma who are getting #immunotherapy. Enrolled patients are randomized to a high-fiber plant based diet and exercise or no intervention. https://t.co/bYZl2r7Lgb
-
-
Mashup Score: 0Early-life gut bacterial community structure predicts disease risk and athletic performance in horses bred for racing - 11 month(s) ago
Scientific Reports – Early-life gut bacterial community structure predicts disease risk and athletic performance in horses bred for racing
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
The gut microbiome is important for health. This study showed that a more diverse #microbiome in 1-month old foals predicted disease and athletic performance in racehorses! https://t.co/Fk8flGAQoW
-
-
Mashup Score: 23Andrea Kunz Biography - 11 month(s) ago
View Andrea Kunz’s Career Biography
Source: www.sitcancer.orgCategories: General Medicine News, Oncologists1Tweet-
Couldn’t be more proud of Andrea! She is an absolutely amazing managing editor of @jitcancer, the leading journal devoted to #immunotherapy for cancer. 👉 https://t.co/Q86pa98yim
-
-
Mashup Score: 16Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020 - 12 month(s) ago
AbstractBackground. We described participant demographics for National Cancer Institute (NCI) clinical trials at the clinical center (NCI-CC participants)
Source: academic.oup.comCategories: General Medicine News, Hem/OncsTweet-
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020 https://t.co/gIpGIZkT1h
-
-
Mashup Score: 1Ipsen to Pay Marengo Therapeutics Up to $1.2 Billion Under Expanded Cancer Research Partnership - 1 year(s) ago
French pharmaceutical company Ipsen is expanding its oncology research partnership with Marengo Therapeutics and will pay the group up to $1.2 billion for the use of its TriSTAR platform.
Source: www.wsj.comCategories: General Medicine News, Hem/OncsTweet-
So proud of @MyOncology and team at Marengo! https://t.co/hZapLc4u6O
-
RT @oncodaily: SITC (@sitcancer) - The Advances in Cancer Immunotherapy https://t.co/R3e51WFPg5 #OncoDaily #Oncology #Cancer #Health #Med…